Delayed notice of non-bioequivalence test items in dispute

The Korean Pharmaceutical Association (KPA) has recently contended that although the drug items subject to the bioequivalence tests were already designated by the Korean Food and Drug Administration (KFDA), its delayed notice of other items excluding from the bioequivalence tests has prevented many pharmacists from using these non-bioequivalence test items as substitute in their dispensing in t...